Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study).

Trial Profile

Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study).

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms ARDENT
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Sep 2009 Actual patient number (242) added as reported by ClinicalTrials.gov.
    • 01 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 01 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top